Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence ISAba36 in the siderophore receptor pirA.
Antimicrob Agents Chemother
; 68(7): e0029024, 2024 Jul 09.
Article
en En
| MEDLINE
| ID: mdl-38809000
ABSTRACT
We report the emergence of cefiderocol resistance in a blaOXA-72 carbapenem-resistant Acinetobacter baumannii isolate from a sacral decubitus ulcer. Cefiderocol was initially used; however, a newly approved sulbactam-durlobactam therapy with source control and flap coverage was successful in treating the infection. Laboratory investigation revealed cefiderocol resistance mediated by ISAba36 insertion into the siderophore receptor pirA.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Infecciones por Acinetobacter
/
Pruebas de Sensibilidad Microbiana
/
Carbapenémicos
/
Cefalosporinas
/
Acinetobacter baumannii
/
Cefiderocol
/
Antibacterianos
Límite:
Humans
/
Male
Idioma:
En
Año:
2024
Tipo del documento:
Article